Pasadena, California
United States
15
2018-07-26
8
2014-12-30
These are the the leading inventors for applications assigned to NEUMEDICINES INC.:
NEUMEDICINES INC. based in Pasadena, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
IL-12 FORMULATIONS FOR ENHANCING HEMATOPOIESIS
#2 | 2016-05-05USES OF IL-12 IN HEMATOPOIETIC IMMUNOTHERAPY (HIT)
#3 | 2016-05-05IL-12 COMPOSITIONS AND METHODS OF USE IN HEMATOPOIETIC RECOVERY
#4 | 2016-02-18ENDOGENOUS VACCINE FOR CANCER AND INFECTIOUS DISEASES
#5 | 2015-12-03METHODS FOR TREATING CANCER USING COMPOSITIONS COMPRISING HSS1 AND/OR HSM1
#6 | 2015-05-28USE OF IL-12 TO INCREASE SURVIVAL
#7 | 2015-04-23USES OF IL-12 AND THE IL-12 RECEPTOR POSITIVE CELL IN TISSUE REPAIR AND REGENERATION
#8 | 2014-12-30 ✅ Patent 8,921,315 granted on 2014-12-30Method of increasing survival of a human subject having exposure to an acute exposure to non-therapeutic whole body ionization by administering a therapeutically effective dose of IL-12
#9 | 2014-12-18 ✅ Patent 9,616,106 granted on 2017-04-11IL-12 for radiation protection and radiation-induced toxicity mitigation
#10 | 2014-11-20 ✅ Patent 9,463,219 granted on 2016-10-11Method for treating brain cancer using a novel tumor suppressor gene and secreted factor
#11 | 2014-07-24 ✅ Patent 9,925,246 granted on 2018-03-27Mitigation of cutaneous injury with IL-12
#12 | 2013-10-03 ✅ Patent 8,846,392 granted on 2014-09-30Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration
#13 | 2013-09-19 ✅ Patent 9,636,381 granted on 2017-05-02Methods for radiation protection by administering IL-12
#14 | 2013-05-23 ✅ Patent 9,878,012 granted on 2018-01-30IL-12 formulations for enhancing hematopoiesis
#15 | 2013-01-10 ✅ Patent 8,735,342 granted on 2014-05-27Method for treating brain cancer using a novel tumor suppressor gene and secreted factor
Also check out Neumedicines, Inc.'s (Pasadena, United States) applicant profile with 4 patent applications submitted.
39410 ⎘